Diane Prager

6.7k citations
56 papers · 5.4k · 2 hit papers · h-index 29

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies

Papers in

Diane Prager

54 papers receiving 5.2k citations

Diane Prager's Hit Papers

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer 2005 · 1.2k citations
1.2k0+7+15Years since publication50010001.5k2.0k

Peers

Diane Prager
Comparison fields: 5 of 103
  • Pulmonary and Respiratory Medicine 3.0k
  • Oncology 2.5k
  • Cancer Research 604
  • Endocrinology, Diabetes and Metabolism 515
  • Molecular Biology 1.3k
Replace Ralf Bützow with:
Ralf Bützow Finland
Kenneth K. Iwata United States
Bjørn Risberg Norway
James M. Kozlowski United States
Barry R. Davies United Kingdom
Tom van Wezel Netherlands
Ralf Brandt United States
Jonathan W. Riess United States
Gilda da Cunha Santos Canada
Aasmund Berner Norway
Diane Prager relative to Ralf Bützow Finland Ralf Bützow's profile →
Citations per field
00.5×5.1×
Ralf Bützow · 1×
Citations per year

Countries citing papers authored by Diane Prager

Since Specialization
Citations

This map shows the geographic impact of Diane Prager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Prager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Prager more than expected).

Fields of papers citing papers by Diane Prager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Prager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Prager. The network helps show where Diane Prager may publish in the future.

Co-authors

The 25 scholars most cited alongside Diane Prager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diane Prager Line = papers co-authored together Diane Prager links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
Hit paper breakdown →
20032121
2
TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
20051207
3 2007233
4 1994167
5
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
1995159
6 2004108
7 2005105
8 199786
9 199683
10 200160
11 199660
12 200659
13 200653
14
IGF-I receptor signalling: lessons from the somatotroph.
199652
15 199745
16 199341
17 199240
18 200440
19 200440
20 200540

About Diane Prager

Diane Prager is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Immunology and Ecology, Evolution, Behavior and Systematics, having authored 56 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), T-cell and Retrovirus Studies (13 papers), Growth Hormone and Insulin-like Growth Factors (13 papers), Vector-Borne Animal Diseases (11 papers), Animal Disease Management and Epidemiology (10 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Oncology (2.5k citations), Cancer Research (604 citations), Endocrinology, Diabetes and Metabolism (515 citations) and Molecular Biology (1.3k citations). Diane Prager has collaborated with scholars based in United States, Hungary and Spain. Frequent co-authors include Roy S. Herbst, Mark G. Kris, Alan Sandler, Chandra P. Belani, Шломо Мелмед, Ronald B. Natale, Michael Wolf, David Cella, Andrea Kay and Joan H. Schiller. Their work appears in journals such as Journal of Clinical Oncology, Blood, Endocrinology, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact